LGND CapEx to Revenue

Ligand Pharmaceuticals Inc · CapEx to Revenue

LGND logo

LGND CapEx to Revenue

Current (TTM)0.10%
LGND CapEx/Revenue (4.51% → 0.10%)
High-resolution chart · PNG

LGND capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.1686%
11.7511%
41.0078%
9.133%
3.6271%
2.7256%
2.1225%
4.7273%
5.0701%
25.9899%
15.1055%
6.9711%
10.0809%
27.5392%
0.2597%
0.2974%
1.3405%
1.8122%
3.4124%
1.2649%
20.1554%
2.2041%
1.9718%
3.2709%
2.5858%
2.2552%
96.577%
13.5593%
8.3172%
1.087%
0.8163%
4.5113%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.